Search Results
Feb 17, 2026, 09:35 ET TEMSA Achieves Record Revenue and All-Time-High Sales in Key European Markets
segments, TEMSA continues to position itself among the industry's most comprehensive electric mobility providers.Backed by nearly two decades of R&D experience in electrification and an in-house battery pack assembly facility, the company designs and develops its own battery management systems and
More news about: TEMSA
Feb 17, 2026, 09:33 ET TEMSA Achieves Record Revenue and All-Time-High Sales in Key European Markets
segments, TEMSA continues to position itself among the industry's most comprehensive electric mobility providers.Backed by nearly two decades of R&D experience in electrification and an in-house battery pack assembly facility, the company designs and develops its own battery management systems and
More news about: TEMSA
Feb 17, 2026, 09:27 ET A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns
https://news.cision.com/scibase/r/a-new-study-demonstrates-that-nevisense-can-predict-atopic-dermatitis-in-newborns,c4308967The following files are available for download:
More news about: SciBase
Feb 17, 2026, 09:08 ET Hexaware and Replit Announce Joint Offerings to Drive Successful Rapid Prototyping to Productionizing for Enterprise Applications
scale.""At Hexaware, we are building an ecosystem of leading technology partners to help our clients get tangible business outcomes from AI," said R. Srikrishna, CEO & Executive Director, Hexaware. "Expanding our partnership with Replit brings together complementary strengths to help customers
More news about: Hexaware Technologies Ltd.
Feb 17, 2026, 09:05 ET Hexaware and Replit Announce Joint Offerings to Drive Successful Rapid Prototyping to Productionizing for Enterprise Applications
scale.""At Hexaware, we are building an ecosystem of leading technology partners to help our clients get tangible business outcomes from AI," said R. Srikrishna, CEO & Executive Director, Hexaware. "Expanding our partnership with Replit brings together complementary strengths to help customers
More news about: Hexaware Technologies Ltd.
Feb 17, 2026, 09:01 ET MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference
peptide-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist. OXM is a naturally-occurring gut hormone that activates GLP1R and GCGR, thereby decreasing food intake while increasing energy expenditure, thus potentially resulting in superior body weight loss compared to selective GLP1R agonists. In
More news about: MetaVia Inc.
Feb 17, 2026, 09:00 ET HABRI and Virbac Join Forces in Support of the Human-Animal Bond
www.habri.org.i Friedmann, E., Gee, N. R., Simonsick, E. M., Studenski, S., Resnick, B., Barr, E., ... & Hackney, A. (2020). Pet ownership patterns and successful aging outcomes in community
More news about: Human Animal Bond Research Institute (HABRI)
Feb 17, 2026, 09:00 ET Daikin and the Astros Foundation Open Applications for $100,000 STEAM Scholarship
and Wharton.Complete the full application by the deadline, including two adult letters of recommendation.A global leader in HVAC&R, Daikin recognizes the role innovation plays in advancing a more sustainable future. As one of the region's largest employers, the company continues
More news about: Daikin Comfort Technologies North America, Inc
Feb 17, 2026, 09:00 ET Quantum Speed Technology Targeting Multi-Trillion-Dollar Infrastructure Efficiency Opportunity
an $8.4 million purchase order to deliver a 108-qubit quantum computer to the Centre for Development of Advanced Computing (C-DAC), India's premier R&D organization of the Ministry of Electronics and Information Technology. The system will be installed on-premises at C-DAC's Bengaluru center and is
More news about: Market News Updates
Feb 17, 2026, 08:30 ET SimuTech Group Named 2025 Worldwide Channel Partner of the Year at Synopsys' Simulation and Analysis Global Sales Conference
spanning sales, support, consulting, and training. SimuTech's team of engineering experts helps organizations solve complex challenges and accelerate R&D outcomes with confidence.CONTACT: Aaron Smith, [email protected]
More news about: SimuTech Group Inc
Feb 17, 2026, 08:30 ET Sanofi announces leadership evolution in Specialty Care Business Unit
advancing its Specialty Care priorities and ensuring continuity of execution during this transition.About SanofiSanofi is an R&D driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. We apply our deep understanding of the
More news about: Sanofi
Feb 17, 2026, 08:15 ET AGCO Brands Showcase Innovations and Autonomous Solutions at 2026 Commodity Classic
field–proven technology solutions like tractor implement management (TIM) and PTx FarmEngage™. The display will feature the MF 9S tractor alongside the 500R sprayer and planter, demonstrating the brand's commitment to delivering practical, high–performance equipment for every operation. Massey Ferguson will
More news about: AGCO Corporation
Feb 17, 2026, 08:11 ET Congressional Leaders and Advocates Applaud the Passage of a Historic Bipartisan $300M Direct Investment In RUTF to End Child Starvation
chain, and demonstrate to the world that the United States remains committed to ending child hunger."Congressman Austin Scott (R-GA)"Continued investment in RUTF production in Georgia provides lifesaving nutrition to malnourished children across the world. This policy
More news about: Malnutrition Advocacy Fund
Feb 17, 2026, 08:05 ET Equisoft's AI-native life insurance platform earns "Luminary" status and XCelent Awards across multiple regions
https://hubs.ly/Q042Y77R0 To learn more about Equisoft/manage, click here:
More news about: Equisoft Inc.
Feb 17, 2026, 08:05 ET Equisoft's AI-native life insurance platform earns "Luminary" status and XCelent Awards across multiple regions
https://hubs.ly/Q042Y77R0 To learn more about Equisoft/manage, click here:
More news about: Equisoft Inc.
Feb 17, 2026, 08:02 ET EPAM Expands AI-Native Agency Empathy Lab in North America to Help CMOs Accelerate AI-enabled Business Growth & Transformation
20 years of experience in leading enterprise growth at several global creative and technology organizations, including Tata Consulting Services and R/GA."I'm excited to bring Empathy Lab's vision to North America at a time when marketing and technology leaders are under growing pressure to modernize
More news about: EPAM Systems, Inc.
Feb 17, 2026, 08:00 ET Mepolizumab May Be Protective Against Small Airway Disfunction Exacerbation Risks in Children
exacerbations during the trial by using negative binomial regression models.The researchers found that greater baseline airway resistance at 5Hz (R5), 5Hz-20Hz (R5-20) and the area under the curve of reactance (AX) were all associated with increased exacerbation risks for the children treated with a placebo.
More news about: American Academy of Allergy, Asthma & Immunology (AAAAI)
Feb 17, 2026, 08:00 ET Castlelake Repays Castlelake Aircraft Structured Trust 2021-1
refinanced Castlelake Aircraft Securitization Trust 2014-1; Castlelake Aircraft Securitization Trust 2014-1R; Castlelake Aircraft Securitization Trust 2015-1; Castlelake Aircraft Structured Trust 2015-1R, Castlelake Aircraft Structured Trust 2016-1, and Castlelake Aircraft Structured Trust 2017-1."With
More news about: Castlelake
Feb 17, 2026, 08:00 ET OFD Life Sciences Expands Leadership as Demand for Lyophilization Accelerates
said Grosso.The addition of a Senior Director of Project Management comes on the heels of 2025 additions to the OFD Life Sciences Quality and R&D teams
More news about: OFD Life Sciences
Feb 17, 2026, 08:00 ET FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month
deletions or exon 21 L858R substitution mutations, as detected by an FDA-approved test.in combination with carboplatin and pemetrexed for the treatment of adult patients with locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R substitution mutations,
More news about: Johnson & Johnson
Feb 17, 2026, 07:58 ET Codoxo Caps Breakout Year with Oversubscribed $35M Series C, Cementing Significant Market Momentum & Leadership in Pre-Claim Payment Integrity
delivered alongside continued enterprise-grade security, achieving NIST 800-53 Revision 5 compliance for the second consecutive year, maintaining HITRUST r2 certification, and advancing toward FedRAMP readiness.Earning Industry Recognition and Expanding the Ecosystem Codoxo's impact was
More news about: Codoxo
Feb 17, 2026, 07:45 ET TuHURA Files Investigational New Drug Application for TBS-2025 in the Treatment of Blood-Related Cancers
antibody, for the treatment of mutNPM1 relapsed/refractory (r/r) Acute Myeloid Leukemia (AML) in combination with a menin inhibitor.The Company plans on initiating a Phase 2 study in menin inhibitor naïve patients with mutNPM1 r/r AML utilizing a Simon 2 stage design. Pending completion of
More news about: TuHURA Biosciences, Inc.
Feb 17, 2026, 07:42 ET Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting
Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with r/r AML, which Actinium is seeking a potential strategic partner for the U.S. In addition, the company's R&D efforts are primarily focused on advancing several preclinical programs for solid tumor indications.
More news about: Actinium Pharmaceuticals, Inc.
Feb 17, 2026, 07:30 ET Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
differentiated MC4R-based obesity programs into clinical developmentMelanocortin-based obesity therapies targeting rare MC4R pathway disorders with a primary focus on hypothalamic obesity and Prader-Willi syndromeOral small-molecule MC4R agonist PL7737
More news about: Palatin Technologies, Inc.
Feb 17, 2026, 07:05 ET Metropolitan Commercial Bank Completes ACH Cloud Migration Powered by Finzly in Landmark Move
payment experiences corporate commercial clients expect."Finzly has been a strong technology partner for Metropolitan Commercial Bank," said Mark R. DeFazio, Founder, President and CEO, Metropolitan Commercial Bank. "Their unified payment platform and modular transformation approach allowed us to
More news about: Finzly